Skip to main content
. 2016 Aug 8;5(8):e250. doi: 10.1038/oncsis.2016.52

Figure 3.

Figure 3

Evaluation of wt-p53 and microRNA-125b (miRNA-125b) transfection in SK-LU-1 lung adenocarcinoma cells and exosomes using plasmid DNA-encapsulated hyaluronic acid-poly(ethylene imine)/hyaluronic acid-poly(ethylene glycol) (HA-PEI/HA-PEG) nanoparticles. (a) Quantitative qRT–PCR analysis of expression of wt-p53 in cells (p53/cells) and in exosomes (p53/exo) when transfected with wt-p53 expressing plasmid DNA alone or in combination with miRNA-125b expressing plasmid DNA in cells (combi/cells) and in exosomes (combi/exo) after 18 h of incubation. (b) Qualitative and quantitative analysis of Flag-p53 protein expression using western blot in cells (p53/cells) and in exosomes (p53/exo) when transfected with wt-p53 expressing plasmid DNA alone or in combination with miRNA-125b expressing plasmid DNA in cells (combi/cells) and in exosomes (combi/exo) after 18 h of incubation. (c) Quantitative qRT–PCR analysis of expression of miR-125b expression in cells (miR-125b/cells) and in exosomes (miR-125b/exo) when transfected with miRNA-125b expressing plasmid DNA alone or in combination with wt-p53 expressing plasmid DNA in cells (combi/cells) and in exosomes (combi/exo) after 18 h of incubation. (*) P<0.05. Data represents mean±s.e.m., n=6.